STAT

Opinion: A chronic illness conundrum: Should I tell my employer about my MS?

I worried about telling my employer I have multiple sclerosis. Doing that can be a good thing. It can also lead to discrimination, or worse.

As I prepared to tell my employer that I have relapsing remitting multiple sclerosis, I worried about what to expect.

Maybe I’d get a shocked look from the administrator who oversees the department where I teach part-time. Or maybe I’d be quietly phased out, informed that future teaching opportunities have dried up.

This “big reveal” would be, according to multiple sclerosis advocates, a risky move.

In its article “,” the National MS Society advises: “Some people have misconceptions about MS and prejudices. Despite your best efforts, they may react negatively toward you, incorrectly viewing you

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks